CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company
SPRUCE BIOSCIENCES, INC.
Sign in to watch- Ticker
- SPRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812154263
- Phone
- (415) 655-4168
- Business address
- 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award Chief Medical Officer acquired 12,378 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 20,000 shares (grant or award)
- 4 Shares withheld for taxes President & CFO gave up 25,936 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 630,400 shares at $3.17 ($1,998,368)
- 4 Open-market buy 10% owner bought 2,208,000 shares at $3.17 ($6,999,360)
- 4 Grant or award Chief Medical Officer acquired 12,864 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 14,705 shares (grant or award)
- 4 Shares withheld for taxes President & CFO gave up 15,293 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 7 · 136 filings